Apyx Medical Corporation (APYX)

Etorro trading 970x250

About Apyx Medical Corporation

Apyx Medical Corporation, a energy technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company’s Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue; and the J-Plasma system allows surgeons to operate in eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida. Address: 5115 Ulmerton Road, Clearwater, FL, United States, 33760

Apyx Medical Corporation News and around…

Latest news about Apyx Medical Corporation (APYX) common stock and company :

SHAREHOLDER ALERT: Morris Kandinov Investigating TSN, VXRT, APYX, and EHTH; Shareholders are Encouraged to Contact the Firm
19 Oct, 2021 Yahoo! Finance

SAN DIEGO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of Tyson Foods, Inc., Vaxart, Inc., Apyx Medical Corporation, and eHealth, Inc. If you are a current owner of shares of any of these stocks, contact leo@moka.law or call (619) 708-3993. Tyson Foods, Inc. (NYSE: TSN) Shareholder Rights Investigation Morris Kandinov is investigating Tyson Foods, Inc. regarding corporate governance failures, possible bre

4 Breakout Stocks for Impressive Returns
05 Oct, 2021 Yahoo! Finance

SB, VTSI, FENC and APYX qualified the screen for breakout stocks for today.

12 Health Care Stocks Moving In Monday's After-Market Session
04 Oct, 2021 FinancialContent

Gainers Longeveron (NASDAQ:LGVN) shares rose 7.69% to $3.64 during Monday's after-market session. The company's market cap stands at ...

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2021 Financial Results on November 11, 2021
04 Oct, 2021 FinancialContent

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today announced that financial results for the third quarter of fiscal year 2021 will be released after the market closes on Thursday, November 11th.

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
29 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA ...

12 Health Care Stocks Moving In Tuesday's After-Market Session
28 Sep, 2021 FinancialContent

Gainers Geovax Labs (NASDAQ:GOVX) shares rose 46.37% to $6.06 during Tuesday's after-market session. This security traded at a ...

Apyx (APYX) Moves 10.9% Higher: Will This Strength Last?
28 Sep, 2021 Yahoo! Finance

Apyx (APYX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
28 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

APYX Falls to Levels Below Book Value
07 Sep, 2021 FinancialContent

In trading on Tuesday, shares of Apyx Medical Corp (APYX) crossed below their last reported book value — defined as common shareholder equity per share — of $11.00, changing hands as low as $10.93 per share. Apyx Medical Corp shares are currently trading down about 3% on the day..

Apyx Medical Corporation to Participate in the Colliers Securities 2021 Institutional Investor Conference
01 Sep, 2021 FinancialContent

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, announced today that management will participate in the Colliers Securities 2021 Institutional Investor Conference, which is being held virtually on Thursday, September 9th. Management will participate in 1x1 meetings. There will be no formal presentation.

 Apyx Medical Corporation Announces Appointment of Wendy Levine to the Company’s Board of Directors
30 Aug, 2021 FinancialContent

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, announced today that the Company has appointed Wendy Levine to the Board of Directors, effective August 25, 2021. Ms. Levine will serve as a Director and member of the Regulatory Compliance Committee.

Apyx Medical Corporation Announces Appointment of Wendy Levine to the Company’s Board of Directors
30 Aug, 2021 Yahoo! Finance

CLEARWATER, Fla., August 30, 2021--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, announced today that the Company has appointed Wendy Levine to the Board of Directors, effective August 25, 2021. Ms. Levine will serve as a Director and member of the Regulatory Compliance Committee.

Notable Friday Option Activity: KODK, APYX, BCRX
13 Aug, 2021 FinancialContent

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Eastman Kodak Co. (KODK), where a total of 8,925 contracts have traded so far, representing approximately 892,500 underlying shares..

77 Biggest Movers From Yesterday
13 Aug, 2021 FinancialContent

Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company ...

12 Health Care Stocks Moving In Thursday's Intraday Session
12 Aug, 2021 FinancialContent

Gainers NanoVibronix (NASDAQ:NAOV) stock increased by 23.8% to $2.86 during Thursday's regular session. As of 12:30 ...

Apyx Medical (APYX) Reports Q2 Loss, Tops Revenue Estimates
12 Aug, 2021 Yahoo! Finance

Apyx (APYX) delivered earnings and revenue surprises of 14.29% and 25.27%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
12 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Apyx Medical Corporation Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Outlook
12 Aug, 2021 FinancialContent

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today reported financial results for its second quarter ended June 30, 2021 and updated its financial outlook for the full year ending December 31, 2021.

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
08 Aug, 2021 FinancialContent

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader ...

Will Apyx Medical (APYX) Report Negative Earnings Next Week? What You Should Know
05 Aug, 2021 Yahoo! Finance

Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Most Shareholders Will Probably Agree With Apyx Medical Corporation's (NASDAQ:APYX) CEO Compensation
31 Jul, 2021 Yahoo! Finance

Despite strong share price growth of 82% for Apyx Medical Corporation ( NASDAQ:APYX ) over the last few years, earnings...

10 Best Medical Stocks Under $10
25 Jul, 2021 Yahoo! Finance

In this article, we will take a look at the 10 best medical stocks under $10. You can skip our detailed analysis of the healthcare industry, and go directly to the 5 Best Medical Stocks Under $10. While the COVID-19 virus spread worldwide, the medical industry proved its resilience and capacity to bring life-saving products […]

We're Hopeful That Apyx Medical (NASDAQ:APYX) Will Use Its Cash Wisely
14 Jul, 2021 Yahoo! Finance

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021
12 Jul, 2021 FinancialContent

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today announced that financial results for the second quarter of fiscal year 2021 will be released before the market opens on Thursday, August 12th.

Apyx Medical Corporation to Participate in the JMP Securities Life Sciences Conference
03 Jun, 2021 FinancialContent

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, announced today that management will participate in the JMP Securities Life Sciences Conference, which is being held virtually from June 16th-17th. Management will participate in a fireside chat on Wednesday, June 16th at 10:30 a.m. Eastern Time.

Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of Renuvion® in Dermal Resurfacing Procedures
01 Jun, 2021 FinancialContent

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today announced it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (“FDA”), which is intended to obtain a specific clinical indication for the use of Renuvion in dermal resurfacing procedures.

ROCE Insights For Apyx Medical
26 May, 2021 FinancialContent

In Q1, Apyx Medical (NASDAQ:APYX) posted sales of $8.64 million. Earnings were up 151.59%, but Apyx Medical still reported an overall ...

Apyx Medical Corporation (NASDAQ:APYX) Just Reported And Analysts Have Been Lifting Their Price Targets
15 May, 2021 Yahoo! Finance

A week ago, Apyx Medical Corporation ( NASDAQ:APYX ) came out with a strong set of quarterly numbers that could...

Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates
12 May, 2021 Yahoo! Finance

Apyx (APYX) delivered earnings and revenue surprises of 0.00% and 9.80%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
12 May, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Apyx Medical Corporation (APYX) is a NASDAQ Common Stock listed in , ,

970x250